Thromboreductin caps 1 mg, , Thromboreductin caps 1 mg 100 pce
7680590310036
CH-59031
L01XX35
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Thromboreductin 1 mg, Kapseln
Kapseln
100
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
anagrelidum
|
1.0 MG | Substance | Wirkstoff (Principe actif) |
|
anagrelidi hydrochloridum monohydricum
|
- | Substance | WIZUS |
|
lactosum monohydricum
|
93.33 MG | Substance | HBESI |
|
povidonum K 29-32
|
- | Substance | HNIDK |
|
crospovidonum
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
|
gelatina
|
- | Substance | HNIDK |
|
aqua
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
Reimbursement information
Public price
CHF 367.90
Specialties list
Yes
Generic
No
SL addition date:
01/04/2011
Authorization holder
OrPha Swiss GmbH
8700 Küsnacht ZH
Authorization information
- Swissmedic authorization number
- 59031
- Drug name
- Thromboreductin, Hartkapseln
- Galenic form
- KAHA
- ATC Code
- L01XX35
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 15/04/2010
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- THROMBOREDUCTIN caps 1 mg bte 100 caps
- Description (DE)
- THROMBOREDUCTIN Kaps 1 mg Ds 100 Kaps
- Market launch
- 15/04/2010
- Market withdrawal
- 01/10/2025
- Narcotic (BTM)
- No